𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mutations in LRRK2 other than G2019S are rare in a north american–based sample of familial Parkinson's disease

✍ Scribed by Nathan Pankratz; Michael W. Pauciulo; Veronika E. Elsaesser; Diane K. Marek; Cheryl A. Halter; Alice Rudolph; Clifford W. Shults; Tatiana Foroud; William C. Nichols


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
64 KB
Volume
21
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

A total of 956 individuals with Parkinson's disease (PD) from 430 multiplex PD pedigrees were screened for 12 previously reported, pathogenic LRRK2 mutations: R793M, L1114L, I1371V, R1441C, R1441G, R1441H, Y1699C, M1869T, I2012T, I2020T, G2385R, and IVS31 +3G>A. Previous screening identified the LRRK2 G2019S mutation in 5% of our families. Only 1 of the 12 newly screened mutations, R1441C, was detected in a single family in our patient cohort. These results indicate that, although the G2019S mutation remains the most common mutation identified in familial PD patients, other mutations in LRRK2 are infrequent. © 2006 Movement Disorder Society


📜 SIMILAR VOLUMES


Lack of G2019S LRRK2 mutation in a cohor
✍ Hon-Chung Fung; Chiung-Mei Chen; John Hardy; Dena Hernandez; Andrew Singleton; Y 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

## Abstract Mutations in the leucine‐rich repeat kinase 2 (__LRRK2__) gene have been shown to cause autosomal dominant and sporadic Parkinson's disease (PD). We report here the frequency of a common heterozygous mutation, 2877510G>A, which produces a glycine‐to‐serine amino acid substitution at cod